Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Effect on Weight Loss of Exenatide Versus Placebo in Subjects With Type 2 Diabetes Participating in a Lifestyle Modification Program

NCT00375492 is registered in ClinicalTrials.gov with AstraZeneca as lead sponsor.

NCT NCT00375492
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00375492 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Effect on Weight Loss of Exenatide Versus Placebo in Subjects With Type 2 Diabetes Participating in a Lifestyle Modification Program
Lead sponsor
AstraZeneca
Phase
Phase 3
Overall status
Completed
Start date
September 30, 2006
Completion date
February 29, 2008
Enrollment
196 (actual)
Sites
10

Conditions

As the registry lists them; a condition with its own page is linked.

type 2 diabetes mellitus